| abstract |
The present invention relates to the use of (thio) -carbamoyl-cyclohexane particularly trans-4- {2- [4- (2,3-dichlorophenyl) -piperazin-1-yl] -ethyl} -N, N-dimethylcarbamoyl-cyclohexylamine derivatives and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Further, the present invention relates to the treatment of schizophrenia by the administration of (thio) -carbamoyl cyclohexane derivatives, particularly trans-4- {2- [4- (2,3-dichlorophenyl) -piperazin-1-yl] -ethyl} -N , N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof. |